US shares of Qiagen rise on Q1 results beat

Qiagen NV

04/05/2023 10:46

** U.S.-listed shares of life-sciences co Qiagen NV  QGEN.N 
up 2.5% to $46.06 in premarket trading
    ** Co posts Q1 revenue of $485.4 mln, topping estimates of
$480.5 mln; boosted by higher sales in its non-COVID-19 product
groups
    ** Reports Q1 adj EPS of $0.51, above estimates of $0.47 -
Refinitiv data
    ** QGEN reaffirmed its full-year 2023 outlook
    ** "Outlook reiterated should be seen as reassuring... we
still see a likely steady beat-and-raise setup for the coming
quarters" - Jefferies
    ** Frankfurt-listed shares of Qiagen  QIA.DE  up around 2.2%
    ** Up to last close, U.S-listed shares of Qiagen had fallen
9.89% so far this year

 (Reporting by Ashwini Raj in Bengaluru)
 ((Ashwini.Raj@thomsonreuters.com))